Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2013 3
2014 2
2015 1
2016 1
2017 1
2018 4
2019 2
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Brittle type 1 diabetes mellitus.
Bertuzzi F, Verzaro R, Provenzano V, Ricordi C. Bertuzzi F, et al. Among authors: provenzano v. Curr Med Chem. 2007;14(16):1739-44. doi: 10.2174/092986707781058922. Curr Med Chem. 2007. PMID: 17627511 Review.
A clinical audit: diagnostic and epidemiological evaluation of the adrenal incidentaloma.
Nuzzo V, Attardo T, Augello G, Brancato D, Canale C, Camerlingo S, Coretti F, Franco A, Giacometti F, Gambacorta M, Loreno M, Maffettone A, Provenzano V, Zuccoli A. Nuzzo V, et al. Among authors: provenzano v. Minerva Endocrinol. 2020 Mar;45(1):18-28. doi: 10.23736/S0391-1977.18.02780-3. Epub 2018 Feb 13. Minerva Endocrinol. 2020. PMID: 29442478
Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.
Ingrasciotta Y, Bertuccio MP, Crisafulli S, Ientile V, Muscianisi M, L'Abbate L, Pastorello M, Provenzano V, Scorsone A, Scondotto S, Trifirò G. Ingrasciotta Y, et al. Among authors: provenzano v. Int J Environ Res Public Health. 2020 Dec 18;17(24):9514. doi: 10.3390/ijerph17249514. Int J Environ Res Public Health. 2020. PMID: 33353081 Free PMC article.
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting.
Simioni N, Berra C, Boemi M, Bossi AC, Candido R, Di Cianni G, Frontoni S, Genovese S, Ponzani P, Provenzano V, Russo GT, Sciangula L, Lapolla A, Bette C, Rossi MC; ReaL (NN2211-4118) Study Group*. Simioni N, et al. Acta Diabetol. 2018 Jun;55(6):557-568. doi: 10.1007/s00592-018-1124-0. Epub 2018 Mar 12. Acta Diabetol. 2018. PMID: 29527621 Free PMC article.
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study.
Lapolla A, Berra C, Boemi M, Bossi AC, Candido R, Di Cianni G, Frontoni S, Genovese S, Ponzani P, Provenzano V, Russo GT, Sciangula L, Simioni N, Bette C, Nicolucci A; NN2211-4118 Study Group. Lapolla A, et al. Among authors: provenzano v. Adv Ther. 2018 Feb;35(2):243-253. doi: 10.1007/s12325-017-0652-2. Epub 2017 Dec 21. Adv Ther. 2018. PMID: 29270781 Free PMC article.
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.
Patti AM, Nikolic D, Magan-Fernandez A, Giglio RV, Castellino G, Chianetta R, Citarrella R, Corrado E, Provenzano F, Provenzano V, Montalto G, Rizvi AA, Rizzo M. Patti AM, et al. Among authors: provenzano v. Diabetes Res Clin Pract. 2019 Mar;149:163-169. doi: 10.1016/j.diabres.2019.02.006. Epub 2019 Feb 10. Diabetes Res Clin Pract. 2019. PMID: 30759365
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M, Rizvi AA, Patti AM, Nikolic D, Giglio RV, Castellino G, Li Volti G, Caprio M, Montalto G, Provenzano V, Genovese S, Ceriello A. Rizzo M, et al. Among authors: provenzano v. Cardiovasc Diabetol. 2016 Dec 3;15(1):162. doi: 10.1186/s12933-016-0480-8. Cardiovasc Diabetol. 2016. PMID: 27912784 Free PMC article. Clinical Trial.
15 results